N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways

• Main Authors: Yan Hu (Author), Zhe Zhao (Author), Yuan-Ting Liu (Author), Ze-Cheng Xu (Author), Jing-Yi Li (Author), Zheng-Yu Yang (Author), Rui-Wang (Author), Yun-Qi Yang (Author), Jia-Hui Zhang (Author), Si-Yuan Qiu (Author), Tao He (Author), Yi-Ying Wu (Author), Sha Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: N-linoleyltyrosine (NITyr), one of the anandamide analogs, exerts activity via the endocannabinoid receptors (CB1 and CB2), which showed anti-tumor effects in various tumors. Therefore, we speculated that NITyr might show anti-non-small cell lung cancer (NSCLC) effects via the CB1 or CB2...